Insights into melanoma: targeting the mTOR pathway for therapeutics.
about
Potential therapeutic effects of the MTOR inhibitors for preventing ageing and progeria-related disordersMultiple cytoskeletal pathways and PI3K signaling mediate CDC-42-induced neuronal protrusion in C. elegans.Itraconazole exerts its anti-melanoma effect by suppressing Hedgehog, Wnt, and PI3K/mTOR signaling pathwaysRecombinant human erythropoietin stimulates melanoma tumor growth through activation of initiation factor eIF4E.SDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanomaAnti-tumor effect of adipose tissue derived-mesenchymal stem cells expressing interferon-β and treatment with cisplatin in a xenograft mouse model for canine melanoma.VS-5584, a Novel PI3K-mTOR Dual Inhibitor, Inhibits Melanoma Cell Growth In Vitro and In VivoLiposomal C6 Ceramide Activates Protein Phosphatase 1 to Inhibit Melanoma CellsMetastatic melanoma - a review of current and future drugsObesity and melanoma: exploring molecular links.Furthering the design and the discovery of small molecule ATP-competitive mTOR inhibitors as an effective cancer treatment.Papillary thyroid microcarcinoma: how to diagnose and manage this epidemic?MicroRNA-9 inhibits the proliferation and migration of malignant melanoma cells via targeting sirituin 1.Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy.MicroRNA-9 suppresses the growth, migration, and invasion of malignant melanoma cells via targeting NRP1.Mechanistic target of rapamycin small interfering RNA and rapamycin synergistically inhibit tumour growth in a mouse xenograft model of human oesophageal carcinoma.High frequency of PTEN mutations in nevi and melanomas from xeroderma pigmentosum patients.Melanoma treatment in review.Exploring major signaling cascades in melanomagenesis: a rationale route for targetted skin cancer therapy
P2860
Q28067037-20ABBD00-3B9B-4344-9504-2CA81A40E8ECQ33573214-0CA780C2-30FA-42D6-8539-81D63DFAA12DQ33709769-6FCFB9A1-1CDC-4B6C-B20B-839D403F3F2AQ33728312-1AADAD1E-84B0-4337-8B5D-83BBB743486FQ33853615-1C26BE9A-D9FA-41B5-B206-89147995AABEQ34990410-8E83D24B-DC2B-4EF2-9CCD-4F9C16C4D350Q35708311-EAD53995-0C75-4E4A-ACE3-C0E657C6C7ABQ36134202-B2A272FE-8FAC-43B7-9495-3F976E53071CQ37450733-74208950-A462-4FD0-A7AB-2A396FFD5DE0Q38095892-94BD13F1-EEB7-41BB-9F44-C1571A928E35Q38106130-12C00DDD-BF85-490F-8B01-D3AE5C7BA67BQ38176686-C7D7A4FA-CE15-4024-B06F-C7CDB4A7271CQ38623618-2C3DE811-4846-4E14-B0FE-28777F34D03DQ38874710-A699C04A-A5B4-4E30-80A1-9FF3B380830EQ39147213-E4543703-CB75-4C89-9ABD-EAE056826CE2Q39233604-0953984E-F92E-4094-9835-BC1B22480E56Q53068627-FA7987BE-7133-455E-8DB2-190609325E7DQ55217220-799404DF-276B-4D5B-85C9-2DD989B53794Q57044361-073ADCFB-D44F-4818-85EC-21EAD55A59DA
P2860
Insights into melanoma: targeting the mTOR pathway for therapeutics.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Insights into melanoma: targeting the mTOR pathway for therapeutics.
@en
type
label
Insights into melanoma: targeting the mTOR pathway for therapeutics.
@en
prefLabel
Insights into melanoma: targeting the mTOR pathway for therapeutics.
@en
P2860
P1476
Insights into melanoma: targeting the mTOR pathway for therapeutics.
@en
P2093
Helena Pópulo
José Manuel Lopes
P2860
P304
P356
10.1517/14728222.2012.691472
P407
P50
P577
2012-05-24T00:00:00Z